HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
Research Article
[키워드] ACE2
ACE2 expression
acute respiratory distress
AGER
alveolar epithelial cell
Biomarker
block
Cell culture
cell death
Chloroquine
Complication
COVID-19
Cytokine storm syndrome
DAMP
death
drug candidate
elevated
entry receptor
Exogenous
expression of SARS-CoV-2
Genetic
glycyrrhizin
HMGB1
Hydroxychloroquine
immune system
immunology
induce
Infectious disease
Inflammation
inhibitor
Microbiology
molecular
morbidity
Mortality
multiple organ failure
pathway
Patient
pharmacological
Sepsis
Septic shock
severe COVID-19
severe COVID-19 patient
siRNA
Spread
syndrome
therapeutic strategy
therapeutic target
thought
Treatment
Virology
[DOI] 10.1016/j.heliyon.2020.e05672 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1016/j.heliyon.2020.e05672 PMC 바로가기 [Article Type] Research Article